Citing 11 cases where their partnership advanced health care, training and learning, the University of Arizona and Banner Health are turning innovation into impact to improve lives across Arizona and beyond from precision medicine to immunotherapy to faster Valley fever diagnoses.

A University of Arizona-led study found that 4-aminopyridine sped up bone fracture repair in mouse models, ramping up the activity of key genes.

Andrews was one of 28 community leaders, professionals and partners to receive awards at the inaugural Community Outreach and Impact Celebration earlier this summer.

Researchers, including Aaron Scott, MD, associate professor of medicine, modified the chemotherapy drug paclitaxel to more effectively target breast and pancreatic cancer tumors.

A study recently published in Nature describes a “previously unrecognized” sense that facilitates communication between the gut and the brain.

The career of physician-scientist Sairam Parthasarathy, MD, tracks with the evolution of sleep science.

The intensive, one-year fellowship offers leadership training with coaching and networking aimed at expanding the national pool of qualified candidates for leadership positions in academic medicine and other health sciences fields.

A new study led by Dr. Stefano Guerra, professor of medicine, will investigate whether levels of the lung protein CC16 in childhood can predict risk of early chronic obstructive pulmonary disease later in life.

WellDOM, a U of A Department of Medicine initiative led by the vice chair Serena Scott, MD, MBA, that began this spring with a faculty survey, prompted new departmental faculty awards and recently sparked a chess club, has led to a broader Wellness Council college- and Banner-wide to refocus on interprofessional wellbeing programs and events.

The award funds a sabbatical for Stefano Guerra, MD, PhD, MPH, to better understand biomarkers that may dictate a child’s developing chronic obstructive pulmonary disease late in life.